Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Total 13F shares
-
19,879,104
-
Share change
-
-804,078
-
Total reported value
-
$93,431,204
-
Put/Call ratio
-
14%
-
Price per share
-
$4.70
-
Number of holders
-
67
-
Value change
-
-$6,727,769
-
Number of buys
-
38
-
Number of sells
-
36
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2024
As of 30 Jun 2024 TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) had 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,879,104 shares of stock of the company.
Largest 10 holders included Essex Woodlands Management, Inc., ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, AIGH Capital Management LLC, PARADIGM CAPITAL MANAGEMENT INC/NY, SILVERARC CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Velan Capital Investment Management LP, FEDERATED HERMES, INC., and Stonepine Capital Management, LLC.
This table shows 67 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.